<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0080)http://www.sec.gov/Archives/edgar/data/1098960/000095014402010130/g78548e8vk.htm --><HTML><HEAD><TITLE>Pilot Therapeutics Holdings, Inc. Form 8-K</TITLE>
<META content="MSHTML 6.00.2900.3020" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff>
<H5 style="PAGE-BREAK-BEFORE: always" align=left>&nbsp;</H5>
<P>
<P align=center><FONT size=2><B>SECURITIES AND EXCHANGE
COMMISSION<BR>Washington, D.C. 20549</B></FONT>
<P align=center><FONT size=2><B>FORM 8-K</B></FONT>
<P align=center><FONT size=2><B>CURRENT REPORT</B></FONT>
<P align=center><FONT size=2><B>PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</B></FONT>
<CENTER>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
   <TR vAlign=bottom>
    <TD width="45%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2><B>&nbsp;January &nbsp;2, 2007 </B>(Date of
      earliest event reported)</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=right><FONT size=2>Commission file number:
      000-28131</FONT></TD></TR></TABLE></CENTER>
<P align=center><FONT size=2><B>Pilot Therapeutics Holdings, Inc.</B><BR>(Exact
name of registrant as specified in its charter)</FONT>
<CENTER>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
   <TR vAlign=bottom>
    <TD width="45%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top align=middle><FONT size=2><B>Delaware</B></FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=middle><FONT size=2><B>56-2280858</B></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top align=middle><FONT size=2>(State or other jurisdiction
      of</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=middle><FONT size=2>(I.R.S. Employer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top align=middle><FONT size=2>incorporation or
      organization)</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=middle><FONT size=2>Identification
  No.)</FONT></TD></TR></TABLE></CENTER>
<P align=center><FONT size=2><B>635 West Fourth Street, Suite
200<BR>Winston-Salem, North Carolina 27101</B><BR>(Address of principal
executive offices)<BR>(Zip code)</FONT>
<P align=center><FONT size=2><B>(336)&nbsp;716-4587</B><BR>(Registrant&#146;s
telephone number, including area code)</FONT>
<P align=center><FONT size=2>&nbsp;</FONT> <!-- PAGEBREAK -->
<P>
<HR noShade>

<P>
<H5 style="PAGE-BREAK-BEFORE: always" align=left>&nbsp;</H5>
<P>
<P align=left><FONT size=2><B>Item&nbsp;7</B></FONT>
<P><FONT size=2>On January 2, 2007, Pilot Therapeutics Holdings, Inc. issued a press release announcing that
it had reengaged American Stock Transfer and Trust Company as its stock transfer agent and registrar to handle
stock transfer issues and that it had reestablished an office in Winston-Salem, NC. A copy
of the press release is attached as Exhibit 99.1 to this report, and is incorporated herein by reference.
<P align=left><FONT size=2><B>Item&nbsp;9</B></FONT>
<P align=left><FONT size=2>EXHIBITS</FONT>
<CENTER>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR vAlign=bottom>
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="86%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>99.1</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>Press Release, dated as of January 2, 2007.</FONT></TD></TR></TABLE></CENTER>
<P align=center><FONT size=2><B>SIGNATURE</B></FONT>
<P><FONT size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of
the Securities Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.
</FONT>
<CENTER>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR vAlign=bottom>
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left colSpan=3><FONT size=2>Pilot Therapeutics
      Holdings, Inc.</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>By: </FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>/s/ Scott Derks </FONT></TD></TR>
  <TR>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left>
      <HR noShade SIZE=1>
    </TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>Scott Derks </FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>President </FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top><FONT size=2>Date: January&nbsp;3, 2007</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT size=2>&nbsp;</FONT></TD>
    <TD><FONT size=2>&nbsp;</FONT></TD>
    <TD vAlign=top align=left><FONT
size=2>&nbsp;</FONT></TD></TR></TABLE></CENTER>
<P align=center><FONT size=2></FONT>&nbsp;</P></FONT></BODY></HTML>
[{"type": "8-K", "sequence": "1", "filename": "jform8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 6412}]
{"company-data": {"conformed-name": "PILOT THERAPEUTICS HOLDINGS INC", "cik": "0001098960", "assigned-sic": "2834", "irs-number": "562280858", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28131", "film-number": "07501018"}, "business-address": {"street1": "101 N. CHESTNUT STREET", "street2": "SUITE 102", "city": "WINSTON-SALEM", "state": "NC", "zip": "27101", "phone": "336-725-2222"}, "mail-address": {"street1": "101 N. CHESTNUT STREET", "street2": "SUITE 102", "city": "WINSTON-SALEM", "state": "NC", "zip": "27101"}, "former-company": {"former-conformed-name": "INTERALLIED GROUP INC /NV/", "date-changed": "19991115"}}
Pilot Therapeutics Holdings, Inc. Form 8-K
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
January  2, 2007
(Date of
      earliest event reported)
Commission file number:
      000-28131
Pilot Therapeutics Holdings, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
56-2280858
(State or other jurisdiction
      of
(I.R.S. Employer
incorporation or
      organization)
Identification
  No.)
635 West Fourth Street, Suite
200
Winston-Salem, North Carolina 27101
(Address of principal
executive offices)
(Zip code)
(336) 716-4587
(Registrant's
telephone number, including area code)
Item 7
On January 2, 2007, Pilot Therapeutics Holdings, Inc. issued a press release announcing that
it had reengaged American Stock Transfer and Trust Company as its stock transfer agent and registrar to handle
stock transfer issues and that it had reestablished an office in Winston-Salem, NC. A copy
of the press release is attached as Exhibit 99.1 to this report, and is incorporated herein by reference.
Item 9
EXHIBITS
99.1
Press Release, dated as of January 2, 2007.
SIGNATURE
Pursuant to the requirements of
the Securities Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.
Pilot Therapeutics
      Holdings, Inc.
By:
/s/ Scott Derks
Scott Derks
President
Date: January 3, 2007